Associate Director, Drug Substance CMC

Centessa Pharmaceuticals, a wholly subsidiary of Eli Lilly and Company, is advancing a portfolio of high‑conviction programs with strong biological validation. Our asset‑centric model offers a unique R&D logic that has been applied by single‑asset companies to improve productivity. This operating model has minimal centralized infrastructure, reduced hierarchy, and exclusive focus on data‑driven capital allocation. Our teams are uniquely incentivized to expeditiously interrogate key scientific hypotheses. We believe the asset‑centric model can lead to improved success rates for programs with greater speed and modest costs. Description of Role Centessa is seeking an Associate Director, Small Molecule Drug Substance Process Chemistry. The successful candidate will work closely with management to direct CDMOs in developing and implementing strategies to deliver advanced chemical intermediates and active pharmaceutical ingredients for use in research, GLP and cGMP studies. This individual will collaborate with several internal departments and third‑party procurement and distribution providers to align objectives and drive decision‑making related to process chemistry and manufacturing. The person will drive the execution of assigned process chemistry activities of Centessa’s small‑molecule pipeline. Travel to vendors both domestically and internationally may be required. Key Responsibilities Direct CDMO team(s) in manufacturing of advanced chemical intermediates and APIs for GLP studies as well as early and late‑stage clinical studies. Review, approve and issue manufacturing batch records. Collaborate with CRO/CDMOs and expert consultants to address process chemistry challenges and develop manufacturing processes that are scalable, safe and cost‑effective. Support contractor sites via meeting updates, remote and on‑site involvement pertaining to OOS/OOT, investigations/deviations, and other pertinent documentation. Provide on‑site presence during active manufacturing campaigns as needed. Prepare presentation materials and clearly communicate progress, challenges and potential risk in API manufacturing to management in real time or weekly basis as needed. Author and review technical reports, tech transfer packages, and GMP production records as well as CMC sections of regulatory‑related documentation (e.g., INDs) submission, and any documents related to intellectual property. Assist with new vendor assessment and selection by providing technical review of CDMO resources, capacities, and capabilities as appropriate for development needs. Aid with plans for technology transfers of drug substances from one supplier to new suppliers. Build and maintain strong relationships with internal and external stakeholders; proactively seek buy‑in and provide ongoing support to address business needs. Escalate and cascade information as needed with discretion. Qualifications PhD in Chemistry, Chemical Engineering, Pharmaceutical Sciences, or a related discipline or MS with extensive relevant biotech/pharmaceutical industry experience. 10+ years of experience in the biotech/pharmaceutical industry in small molecules, working in early to late development (pre‑clinical to Phase 3). Extensive experience in process chemistry development, scale‑up, tech transfer and process characterizations, as well as deep understanding of GMP/GLP regulations. Demonstrated experience with managing project teams, CDMOs and other vendors. Proven expertise in process chemistry and early and late‑stage API manufacturing and ability to coordinate CDMO activities in the development and commercialization of pharmaceutical products. Thorough understanding of cGMP requirements for pharmaceutical products; ability to work independently in a fast‑paced dynamic environment with multiple projects. Strong analytical, organizational and decision‑making skills. Must be willing to travel both domestically and internationally approximately 15%–20% of the time. Compensation The annual base salary range for this position is $190,000.00 to $220,000.00. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience and job knowledge. In addition to base pay, this role is eligible for a discretionary annual bonus. Centessa also offers a comprehensive benefits package, which includes a 401(k) plan, company‑sponsored medical, dental, vision and life insurance, generous paid time off, and a health and wellness program. Work Location The Associate Director, Drug Substance CMC role is based in the United States, with occasional travel (15%–20%). POSITION: Full‑Time, Exempt EEOC Statement: Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, believes in a diverse environment and is committed to equal employment opportunity for all employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability or any other legally protected status. We will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law. We will not assign referral rights for any unsolicited resumes from recruitment agencies. #J-18808-Ljbffr Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company